Emerging respiratory medicines and treatments, including robotic navigation and gene-editing nanoparticles, may significantly improve patient outcomes in the future for prevalent pulmonary diseases like lung cancer, cystic fibrosis, and chronic obstructive pulmonary disease.
Every month, the M3 Pulse covers one of the hottest topics in healthcare. Share your opinion and find out what some of your colleagues think about the latest topic. The M3 Pulse consists of a single-question survey that we send to our…
Read More M3 Pulse: a window to the hottest topics in healthcare
Artificial intelligence in healthcare is an ongoing hot topic for the experts. A.I. tools and inexpensive diagnostic software could soon become as essential to physicians as the stethoscope was in the past. AI can be sliced and diced many different…
| Topic | Methodology | Country | Incentive |
|---|---|---|---|
|
Asthma Treatments |
Online survey 30-min. |
Italy/ United Kingdom
|
|
|
Cancer treatment trends |
Online survey 20-min. |
France/ Germany/ United States
|
|
|
COPD |
Online survey 10-min. |
Germany |
|
|
Interstitial Lung Diseases (ILDs) |
Online survey 60-min. |
United States/
|
|
|
NSCLC [Non Small Cell Lung Cancer] |
Online survey 10-min. |
France/ Germany/ Italy/ Spain |
|
|
Pulmonary Hypertension |
Online survey 30min. |
United States |
*Please note that studies are subject to availability and invites are dependent upon a range of criteria. As such, the studies listed above may not always match the studies available on your dashboard
